2016 Shire OBU = best rep job ever and a leadership team that trusted the reps. Actually felt like the upside down pyramid story was true. And it was only the beginning, with not only Xiidra but a promising pipeline.
2017 Shire OBU = leadership that panics and makes decisions based on 1 or 2 weeks worth of data combined with not knowing how to construct an IC plan that works, much less construct one that is in place before the IC period ends. Oh, and what happened to that great pipeline? R&D head leaves and apparently so did some of the ophthalmic pipeline as well. We only have 1 product in development now and no communication on what happened to glaucoma & other rare diseases.